Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Kidney Disease Treatment May Harm Patients

15.10.2007
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease. One technique, inserting a catheter through large vessels, has been commonly used worldwide in recent years.

A new study published in Hemodialysis International finds that this treatment may block the blood flow in the vessel, leading to superior vena cava syndrome (SVC syndrome), a highly serious complication caused by the obstruction of blood coming to the heart from the upper body.

The warning signs of SVC syndrome include shortness of breath, swelling of the upper limbs, neck and face, which occur as the catheter, generally inserted into a large blood vessel, blocks blood flow. The study stresses the need for clinicians to be able to identify SVC syndrome symptoms in order to prevent more serious complications.

“The increasing use of central vein catheters for long-term hemodialysis has contributed high rates of complications,” concludes Hadim Akoglu, M.D., author of the study. “It seems that SVC syndrome due to central vein catheters will become an important threat as the popularity of this treatment continues to grow.”

Akoglu suggests that the harmful effects of SVC syndrome can be counteracted if catheters are only used for short periods of time. Treatments for SVC syndrome are also being devised, including thrombolytic therapy, where blood clots are pharmacologically dissolved; percutaneous transluminal balloon angioplasty (PTA); intravascular stent placement; and surgical reconstruction, which re-opens blood flow access in the vessel.

Sean Wagner | alfa
Further information:
http://www.blackwellpublishing.com/press/pressitem.asp?ref=1460

More articles from Health and Medicine:

nachricht PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>